Received Oct 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
Skin reaction; This non-serious case was reported by a consumer and described the occurrence of skin reaction in a 75-year-old male patient who received Herpes zoster (Herpes Zoster vaccine) for prophylaxis. Concomitant products included triamcinolone acetonide. On an unknown date, the patient received the 2nd dose of Herpes Zoster vaccine. On an unknown date, an unknown time after receiving Herpes Zoster vaccine, the patient experienced skin reaction (Verbatim: Skin reaction). The outcome of the skin reaction was not resolved. It was unknown if the reporter considered the skin reaction to be related to Herpes Zoster vaccine. It was unknown if the company considered the skin reaction to be related to Herpes Zoster vaccine. Additional Information: GSK Receipt Date: 18-SEP-2025 Patient reported that he had skin rash after second shot. Dermatologist has no answers, or remedies. Patient has this condition for one year.
TRIAMCINOLONE ACETONIDE